Itvisma (onasemnogene abeparvovec-brve) demonstrated improved motor function and stabilization in patients regardless of SMA treatment history in Phase ...
BridgeBio jumps on major clinical wins, strong launches and rare-disease programs targeting large markets with new drugs ...
Ad hoc announcement pursuant to Art. 53 LR Itvisma (onasemnogene abeparvovec-brve) demonstrated improved motor function and stabilization in patients regardless of SMA treatment history in Phase III ...
Merck plans a Phase 3 trial of Winrevair after a Phase 2 study testing it in CpcPH due to HFpEF hit its main goal.
Tech Savvy Mama on MSN
Best Gifts for Outdoor Lovers
The links in this Favorite Gifts for Outdoor Lovers post are affiliate links and I’ll receive a small commission if you make ...
A compound that enables the delivery of insulin through the skin has been demonstrated in mice and minipigs. The findings, ...
News-Medical.Net on MSN
Research explores new solvent strategies to extend shelf life of injectable therapeutics
Kennesaw State University Assistant Professor of Chemistry and Biochemistry Mohammad Halim has received a three-year National ...
The cryptocurrency market remained weak on Wednesday, as Bitcoin continued to struggle around $90,000. Altcoins display mixed ...
IT white papers, webcasts, case studies, and much more - all free to registered TechRepublic members. Enforce identity-theft safeguards with a customizable policy that protects sensitive employee and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback